{
    "Trade/Device Name(s)": [
        "MySet\u2122M Pregnancy Test"
    ],
    "Submitter Information": "Ani Biotech Oy",
    "510(k) Number": "K053138",
    "Predicate Device Reference 510(k) Number(s)": [
        "K980531"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "March 1, 2006",
    "Summary Letter Received Date": "January 17, 2006",
    "Submission Date": "January 14, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay"
    ],
    "Methodologies": [
        "Monoclonal antibody-based detection"
    ],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for MySet\u2122M Pregnancy Test, a lateral flow immunoassay for qualitative detection of hCG in urine for early pregnancy determination",
    "Indications for Use Summary": "Qualitative determination of human chorionic gonadotropin (hCG) in urine for early detection of pregnancy; for over-the-counter use",
    "fda_folder": "Clinical Chemistry"
}